➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Patent: 7,462,349

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,462,349
Title:Beta interferon for the treatment of chronic spinal cord injury
Abstract: The invention is intended to adapt an already established clinical procedure for the treatment of multiple sclerosis (MS)--the use of beta interferon--to treat chronic human spinal cord injury. The present invention relates to the prevention of chronic inflammation and demyelination following spinal cord injury.
Inventor(s): Kalderon; Nurit (New York, NY)
Application Number:10/693,042
Patent Claims:see list of patent claims

Details for Patent 7,462,349

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Serono Inc REBIF interferon beta-1a SYRINGE 103780 002 2002-03-07   Start Trial 2022-10-24 RX search
Serono Inc REBIF interferon beta-1a SYRINGE 103780 001 2002-03-07   Start Trial 2022-10-24 RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17   Start Trial 2022-10-24 RX search
Bayer Healthcare Pharms BETASERON interferon beta-1b VIAL; SUBCUTANEOUS 103471 001 1993-07-23   Start Trial 2022-10-24 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.